Vor Biopharma (VOR) Preferred Shares Issued (2020 - 2021)
Vor Biopharma (VOR) reported Preferred Shares Issued of $45.4 million for Q1 2021, up 156.08% year-over-year from $17.7 million in Q1 2020, and up 12064.88% quarter-over-quarter from $373000.0 in Q3 2020.
Vor Biopharma (VOR) Preferred Shares Issued (2020 - 2021) Analysis & Trends
Vor Biopharma (VOR) has 2 years of Preferred Shares Issued data on file, last reported at $45.4 million in Q1 2021.
- Preferred Shares Issued for Q1 2021 came in at $45.4 million, up 156.08% year-over-year; the trailing twelve-month figure through Dec 2021 was $45.4 million (down 44.84% YoY), and the FY2021 annual result was $45.4 million, down 44.84% from the prior year.
- Preferred Shares Issued rose to $45.4 million in Q1 2021 per VOR's latest filing, from $373000.0 in the prior quarter.
- Over five years, Preferred Shares Issued peaked at $64.2 million in Q2 2020 and troughed at $373000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vor Biopharma | 627.54 Mn | 627.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 45.38 Mn |
| Mar 31, 2021 | 45.38 Mn |
| Sep 30, 2020 | 373,000.00 |
| Sep 30, 2020 | 373,000.00 |
| Jun 30, 2020 | 64.18 Mn |
| Jun 30, 2020 | 64.18 Mn |
| Mar 31, 2020 | 17.72 Mn |
| Mar 31, 2020 | 17.72 Mn |